Target intelligence / Profile preview

30S ribosomal subunit (Escherichia coli) (30S subunit)

Target
30S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The 30S ribosomal subunit is the smaller component of the 70S prokaryotic ribosome in Escherichia coli, consisting of the 16S ribosomal RNA (rRNA) and 21 ribosomal proteins (UniProt). It plays a critical role in the initiation of translation and the decoding of genetic information by ensuring the correct pairing between mRNA codons and tRNA anticodons (PubMed). Because of its essential role in bacterial protein synthesis and its structural differences from the eukaryotic 40S subunit, it is a primary target for several classes of antibiotics (StatPearls). Drugs like aminoglycosides and tetracyclines bind to specific sites within the 30S subunit to either induce translational errors or physically block the entry of aminoacyl-tRNA (PubChem). Understanding its structure and function is vital for addressing bacterial infections and the growing challenge of antimicrobial resistance (PubMed).

Other names
Small ribosomal subunitProkaryotic small ribosomal subunit16S ribonucleoprotein complex16S rRNA-protein complex
02

Mechanism of action

Antibiotics targeting the 30S subunit primarily inhibit protein synthesis through two mechanisms: aminoglycosides bind to the 16S rRNA A-site to induce mRNA misreading and mistranslation (PubMed), while tetracyclines bind to the subunit to physically block the docking of aminoacyl-tRNA to the A-site (StatPearls).

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingtRNA bindingTranslation
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityOtotoxicityVestibulotoxicityNeuromuscular blockadePermanent tooth discoloration in childrenPhotosensitivityDisruption of the gut microbiome
06

Interacting drugs

Streptomycin

12 more in the full profile.

07

Biomarkers

16S rRNA gene sequencingMinimum Inhibitory Concentration (MIC)Aminoglycoside-modifying enzymes (AMEs)16S rRNA methyltransferasesrrs gene mutations

Beyond the preview

Go deeper on 30S ribosomal subunit (Escherichia coli) (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S ribosomal subunit (Escherichia coli) (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call